Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1.
Bobby George NgCarla G AsteggianoMartin KircherKati J BuckinghamKimiyo RaymondDeborah A NickersonJay ShendureMichael J Bamshadnull nullMatthias EnsslenHudson H FreezePublished in: American journal of medical genetics. Part A (2017)
Transport of activated nucleotide-sugars into the Golgi is critical for proper glycosylation and mutations in these transporters cause a group of rare genetic disorders termed congenital disorders of glycosylation. We performed exome sequencing on an individual with a profound neurological presentation and identified rare compound heterozygous mutations, p.Thr156Arg and p.Glu196Lys, in the CMP-sialic acid transporter, SLC35A1. Patient primary fibroblasts and serum showed a considerable decrease in the amount of N- and O-glycans terminating in sialic acid. Direct measurement of CMP-sialic acid transport into the Golgi showed a substantial decrease in overall rate of transport. Here we report the identification of the third patient with CMP-sialic acid transporter deficiency, who presented with severe neurological phenotype, but without hematological abnormalities.